Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

 

Memorial Sloan Kettering Cancer Center
N

HER2- Directed Targeted Agents for Brain Metastasis in Metastatic Breast Cancer

By Memorial Sloan Kettering Cancer Center FEATURING Neil Iyengar
By Memorial Sloan Kettering Cancer Center FEATURING Neil Iyengar
653 views
March 15, 2022
0 Comments
Login to view comments. Click here to Login

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay
Breast
06:55
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "EMBER Study - Imlunestrant+/-Everolimus or…

Feat. K. Jhaveri
21:26
Memorial Sloan Kettering Cancer Center

Early Diagnosis and Updates in Breast Cancer

Feat. V. Sacchini
27:27
Nebraska Oncology Society

ASCO 2022 HR+ Breast Cancer Updates

Feat. C. Dang
05:51
Nebraska Oncology Society

ASCO 2022 on the Phase 3 DESTINY-Breast 03 Trial: HER2+ BC Updates

Feat. C. Dang
09:47
Nebraska Oncology Society

ASCO 2022 on the Phase 3 KEYNOTE-522 Trial: TNBC Updates

Feat. C. Dang
09:57
ASCO 2022 Conference Coverage

ASCO 2022 Preliminary Analysis of an Expanded Access Study of the Fi…

Feat. C. Dang
01:06
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Preliminary Analysis of an Expanded Acce…

Feat. C. Dang
05:41
ecancer

ASCO 2022 DESTINY-Breast04: Trastuzumab Deruxtecan Doubles PFS in MB…

Feat. S. Modi
05:57
ecancer

ASCO 2022 DESTINY-Breast04: Trastuzumab Deruxtecan vs. Treatment of …

Feat. S. Modi
06:32
ASCO 2022 Conference Coverage

ASCO 2022 on Characterization of Alpelisib-Associated Hyperglycemia …

Feat. S. Shen
01:37
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on Characterization of Alpelisib-Associa…

Feat. S. Shen
20:08
Memorial Sloan Kettering Cancer Center

HER2- Directed Targeted Agents for Brain Metastasis in Metastatic Br…

Feat. N. Iyengar
28:05
University of Kansas Cancer Center Post San Antonio Review

2022 Inherited Breast Cancer Risk Assessment and Reduction: What…

Feat. M. Robson
53:46
PleXus Communications

HR+ Breast Cancer: Individualizing Therapy With CDK 4/6 Inhibitors

Feat. K. Jhaveri
07:16
SABCS 2021 Conference Coverage on VuMedi

SABCS 2021 Results of a Prospective Screening Study: Impact of Race …

Feat. A. Barrio
13:08
SABCS 2021 Conference Coverage on VuMedi

SABCS 2021 Updates on Neratinib + Fulvestrant + Trastuzumab for HR+/…

Feat. K. Jhaveri
24:21
SABCS 2021 Conference Coverage on VuMedi

SABCS 2021 Update on Oligoprogressive Disease in BC: Treating Locall…

Feat. A. Xu
20:23
Memorial Sloan Kettering Cancer Center

Will Surgery Be a Part of Breast Cancer Treatment in the Future?

Feat. M. Morrow
26:50
5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure

CAR-T Cell Therapy for Breast Cancer: Types of T-Cell Therapy, Ident…

Feat. S. Modi